PulseAugur
EN
LIVE 20:08:37
ENTITY Xingyao Kunze

Xingyao Kunze

PulseAugur coverage of Xingyao Kunze — every cluster mentioning Xingyao Kunze across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
  1. 2026-05-26 funding Fosun Pharma is investing 414 million yuan in Xingyao Kunze's Series B funding round and acquiring shares from existing investors. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_51978 ·

    Fosun Pharma invests 414M yuan in liver disease drug developer Xingyao Kunze

    Fosun Pharma is investing 414 million yuan in a Series B funding round for Xingyao Kunze, a company focused on innovative liver disease drugs. This investment, which includes acquiring shares from existing shareholders,…